Paloma Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
Paloma Partners's SYNH Position: Q4 2021 in Review
Paloma Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 3,490 shares — an estimated $305K sold.
Paloma Partners first reported a position in SYNH in Q4 2015 and held it in 13 quarters. The position peaked at $7.18M in Q2 2020. 378 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.
- Paloma Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
- Paloma Partners sold 3,490 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $305K.
- Paloma Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 13 quarters.
- Paloma Partners's Syneos Health, Inc. Class A Common Stock position peaked at $7.18M in Q2 2020.
- 378 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.
Based on Paloma Partners's 13F filing for Q4 2021, filed 14 Feb 2022.